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Abstract: Trauma is a major public health problem worldwide. Infectious complications, sepsis, and multiple organ 
dysfunction syndrome (MODS) remain important causes for morbidity and mortality in patients who survive the initial 
trauma. There is increasing evidence for the role of genetic variation in the innate immune system on infectious 
complications in severe trauma patients. We describe a trauma patient with multiple infectious complications caused by 
multiple micro-organisms leading to prolonged hospital stay with numerous treatments. This patient had multiple single 
nucleotide polymorphisms (SNPs) in the MBL2, MASP2, FCN2 and TLR2 genes, most likely contributing to increased 
susceptibility and severity of infectious disease. 
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INTRODUCTION 
 Trauma is a major public health problem worldwide, 
ranking as the fourth leading cause of death. In 2010, there 
were 5.1 million deaths from injuries and the total number of 
deaths from injuries was greater than the number of deaths 
from HIV/AIDS, tuberculosis, and malaria combined (3.8 
million) [1, 2]. Infectious complications, sepsis and multiple 
organ dysfunction syndrome (MODS) remain important 
causes for morbidity and mortality in patients who survive 
the initial trauma [3, 4]. These complications increase the 
burden of cost to society. 
 There is increasing evidence for the role of genetic 
variation in the innate immune system on infectious 
complications in sepsis and trauma [5-10]. We describe a 
trauma patient with multiple infectious complications caused 
by multiple micro-organisms leading to prolonged hospital 
stay with numerous treatments. This patient had multiple 
single nucleotide polymorphisms (SNPs) in the innate 
immune system, most likely contributing to increased 
susceptibility and severity of infectious disease. 
SINGLE NUCLEOTIDE POLYMORPHISMS 
 Humans have 23 pairs of chromosomes and, on average, 
all humans are 99.9% similar to any other human in terms of 
DNA sequence. The remaining 0.1% account for all the  
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differences between humans These differences are known as 
‘polymorphisms’. The coding regions of DNA contain the 
approximately 20,000 human protein-coding genes. The 
coding regions take up less than 2% of all DNA. More than 
98% of the human genome is composed of non-coding DNA 
of which the function is partly unknown. Human diploid 
cells contain around six billion base pairs. These base pairs 
are pairs of nucleotides, the building blocks of DNA (A, C, 
T, and G). 
 Single Nucleotide Polymorphisms (SNPs; pronounced 
‘snip’, plural ‘snips’) are variations of only one nucleotide in 
the sequence of DNA. Around 90% of all DNA variation is 
caused by SNPs making them the most common type of 
sequence variation. To date more than 60 million SNPs have 
been discovered in the human genome. 
 SNPs in coding regions of DNA may have the potential 
to alter the amino acid sequence in a protein but as a result of 
degeneracy this is not always the case; some proteins are 
coded by more than one codon. SNPs in coding regions are 
called synonymous if they do not affect the amino acid 
sequence and non-synonymous if they do influence the 
amino acid sequence of a protein. The non-synonymous 
SNPs can be divided into missense SNPs and nonsense 
SNPs. Missense SNPs result in the transcription of a 
different amino-acid, changing the functionality of the 
resulting protein as is the case in Factor V Leiden 
thrombophilia [11] and sickle cell disease [12]. A nonsense 
SNP results in the formation of a premature stopcodon 
leading to a truncated, incomplete protein as is the case in β-
thalassemia in Sardinia [13] and some forms of cystic 
fibrosis [14]. 
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CASE REPORT 
 Patient A, a 57 year old mechanic with a medical history 
of occasional use of cocaine and of gradually worsening 
vision in the last five months as a result of optic nerve 
atrophy tripped over a low brick wall at work and fell about 
one meter on the back of his head. He was immediately 
found to be tetraplegic by the paramedics and was 
transferred to a level 1 trauma center. Clinically, the 
complete cord lesion was found to be on the level of C3 and 
C4. Computed tomography showed a congenital narrowing 
of the spinal canal at the level of C3 and C4 as well as an old 
fracture of the third thoracic vertebra (Fig. 1). Magnetic 
resonance scanning showed hemorrhage in the myelum at 
the level of C3 and C4 as the reason for the tetraplegia (Fig. 
2). 
 
Fig. (1). Computed tomography of discussed patient showing the 
congenital narrowing of the spinal canal at the level of C3 and C4. 
Also, a preexisting injury at the level of T2 and T3 can be seen.  
 He was transferred to the Intensive Care Unit for 
ventilator support. On day 3 he developed acute respiratory 
distress syndrome (ARDS) and pneumonia in the right lower 
lobe, possibly as a result of aspiration, from which purulent 
sputum was removed repeatedly. The sputum grew Haemo-
lytic Streptococcus group C, Streptococcus pneumoniae, 
Haemophilus influenzae and Enterobacter cloacae for which 
he was treated with piperacillin/tazobactam. On day 10 a 
percutaneous tracheostomy was used and weaning was 
possible. On day 20 patient was no longer dependent on 
ventilator support. He spent a total of 32 days on the 
Intensive Care Unit and 76 days in the hospital before being 
discharged to a rehabilitation center. After three months he 
was admitted again, this time to the department of Internal 
Medicine, for fever, diarrhea and productive cough. 
Radiology was suspect for pulmonary tuberculosis and  
 
 
Fig. (2). Magnetic resonance scanning of discussed patient shows 
bleeding in the myelum at the level of C3 and C4 as the cause for 
his complete cord syndrome. 
Mycobacterium tuberculosis was eventually found in gastric 
contents. He was placed on tuberculostatic triple therapy. His 
diarrhea was explained by pseudomembranous colitis caused 
by Clostridium toxins. He was given metronidazol and was 
free of diarrhea after ten days. He developed deep venous 
thrombosis in the right subclavian vein ultimately leading to 
erysipelas and ulceration on the fingers from which 
Escherichia coli, Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Morganella morganii and Proteus mirabilis 
were cultured. The urine was positive for Klebsiella 
pneumoniae and Enterococcus faecalis. The ulcers were 
treated surgically. 
 Because this patient participated in a scientific trial 
studying genetic variation in trauma patients, his genome 
was sequenced for several single nucleotide polymorphisms 
(SNPs). Several SNPs were found: heterozygosity in MBL2 
exon 1 (i.e., AC genotype), heterozygosity in MBL2 promoter 
region Y-221X, (YX genotype) homozygosity for the minor 
allele in MASP2 Y371D (DD genotype), heterozygosity in 
FCN2 T236M (TM genotype), heterozygosity in FCN2 
A258S (AS genotype), homozygosity for the minor allele in 
TLR2 T-16934A (AA genotype), and heterozygosity in 
CD14 C-159T (CD genotype). 
DISCUSSION 
 Mortality as a result of sepsis in the third peak of 
Trunkey [15] has not changed in recent times despite the 
improvements in treatments in the Intensive Care Unit 
leading to reduction in the incidence of sepsis itself [4]. The 
onset of sepsis in trauma patients is of course multifactorial, 
but genetic variation at the level of the innate immune  
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system is certainly one important contributing factor. SNPs 
in genes coding for important proteins in the innate immune 
system, such as the complement system, may produce low 
serum levels of these proteins or they may leave these 
proteins dysfunctional. Hence, the immune response and 
cytokine response to trauma and infection is reduced leading 
to increased susceptibility and severity of infectious 
complications. These complications cause prolonged hospital 
stay and increase the use of antibiotics, the number of 
complications, and the cost of care to society. 
 The above presented patient was proband in a prospective 
study in severely injured trauma patients focusing on SNPs 
in the innate immune system and the influence on infectious 
complications. A number of SNPs were found in this patient 
(see Table 1). 
 In the lectin pathway of complement activation three 
important genes were studied: MBL2, MASP2, and FCN2. 
The MBL2 gene encodes for mannose-binding lectin (MBL), 
a protein that is secreted by the liver as part of the acute-
phase response and is involved in innate immune defense. 
The ligands for MBL are expressed by a wide variety of 
microorganisms, and binding of the protein leads to 
opsonisation of the pathogen as well as activation of the 
complement system. Genetic variation in this gene leads to a 
dramatic decrease in circulating serum MBL. Heterozygosity 
for variants in exon 1 (i.e., an A0 genotype) conferred an 
increased risk for wound colonization and infection in 
severely injured patients [6]. This had previously only been 
demonstrated in a murine model of burns [16]. Also, the YX 
promoter genotype increased the risk of fungal colonization 
and infection in trauma patients [6]. Presented patient carried 
an AC genotype in exon 1 and a YX genotype in the 
promoter region. MBL activates the complement pathway 
through mannan-binding lectin serine protease 2 (MASP2). 
MASP2 Y371D DD homozygosity significantly increased 
the risk for SIRS and septic shock in trauma patients [6]. 
Moreover, a trend was noted for an increased risk of Gram-
positive infections in patients with MASP2 Y371D DD 
genotype. Above presented patient carried the MASP2 
Y371D DD genotype. FCN2 encodes for Ficolin-2, 
previously termed L-ficolin, a protein which is mainly 
produced in the liver and has been shown to have 
carbohydrate binding and opsonic properties in the innate 
immune system. The homozygous FCN2 A258S AS 
genotype increased the risk for developing septic shock in  
 
 
trauma patients [6]. Also, wound colonization and infection 
were significantly increased. A trend was noted for Gram-
negative infections. In this article presented patient carried 
the FCN2 A258S AS genotype. 
 Deficiencies in the lectin pathway have been linked to 
susceptibility of various pathogens, for example MASP 
deficient mice are highly susceptible to Streptococcus 
pneumoniae [17] and also children [18] and adults [19] 
have previously been shown to be highly susceptible to S. 
pneumoniae with deficiencies in MBL and MASP2. In 
children lectin pathway deficiencies may play a role in 
Haemophilus influenzae [20] but this was not found in a 
cohort of adults with community acquired pneumonia [21]. 
The effect of MBL genotype on the susceptibility to 
Mycobacterium tuberculosis is controversial [22, 23]. In 
burn injury patients [16] and cystic fibrosis patients [24] 
MBL deficiency plays an important role on susceptibility to 
Pseudomonas aeruginosa infection and colonization. The 
FCN2 A258S polymorphism was previously shown to 
influence susceptibility to leprosy [25], influence 
colonization with Pseudomonas aeruginosa in cystic 
fibrosis patients [24] and influence renal transplant outcome 
[26]. 
 As a membrane surface receptor, TLR-2 recognizes many 
bacterial, fungal, viral, and certain endogenous substances. 
The TLR2 T-16934A polymorphism was previously linked to 
spontaneous bacterial peritonitis in liver cirrhosis patients 
[27], atopic dermatitis, asthma and wheezing [28-30] and 
sarcoidosis [31]. The TLR2 T-16934A genotype was studied 
in a trauma population by one author [7] who found that the 
TLR2 T-16934A TA genotype increased the risk of a Gram-
positive infection and SIRS. The TLR2 T-16934A AA 
genotype seemed to protect against urinary infection, oddly. 
However, patient A carried the TLR2 T-16934A AA genotype 
but developed positive urine cultures. 
 Infectious complications are multifactorial in origin. 
SNPs in the innate immune system contribute to 
susceptibility and severity of these infections and lead to 
prolonged hospital stay and increased cost. The presented 
patient demonstrates the clinical course of such 
complications that will be recognized by all surgeons. In the 
future we expect that initial genotyping will become routine 
workup in all trauma patients to quantify the individual risk 
for developing infections. Patients identified to be at risk for 
developing infectious complications can be prophylactically  
 
 
Table 1. Genotypes found in presented patient. 
 
Gene SNP OMIM Cytogenic Location dbSNP ID Genotype of Our Patient 
MBL2 exon 1  codon 57 [C allele]  154545 10q21 rs1800451 AC 
MBL2 promoter Y-221X 154545 10q21 rs7096206 YX 
MASP2 Y371D 605102 1p36 rs12711521 DD 
FCN2 A258S 601624 9q34 rs7851696 AS 
TLR2 T-16934A 603028 4q31 rs4696480 AA 
SNP: single nucleotide polymorphism. OMIM: Online Mendelian Inheritance in Man, an online catalog of human genes and genetic disorders. dbSNP ID: Single Nucleotide 
Polymorphism Database, a free public archive for genetic variation hosted by the National Center for Biotechnology Information [NCBI]. 
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treated with antibiotics in an early stage or can be 
supplemented with plasma from mixed donors containing the 
deficient proteins. Substitution therapy with purified or 
recombinant proteins has also produced clinical results, for 
example in the case of MBL-deficiency [32-36]. Further 
studies are needed in order to determine which genes affect 
this risk and to quantify their effect. 
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